Slovenia's main Covid treatment facility will suspend the use of monoclonal antibody treatment because it proved to be inefficient against Omicron, the head of the UKC Ljubljana Department of Infectious Diseases, Tatjana Lejko Zupanc, told the STA on Thursday.
This post was originally published on STA.